Causal Nexus Requirement for Showing Irreparable Harm in Multi-consumer, Multi-Feature Products Only Requires An infringing Feature to be “A Driver” of Demand

GENBAND v. METASWITCH: July 10, 2017. Before Lourie, Taranto, and Chen.   Takeaway: In multi-consumer, multi-feature products, the causal nexus requirement for showing irreparable harm can be satisfied by evidence showing that an infringing feature increases a product’s desirability, or evidence showing that the absence of the feature would make …

CAFC reverses and remands denial of a preliminary injunction against the defendants’ use of trade secret and proprietary information and the denial of a lifting of the stay as to the non-patent counts of the complaint

  Case: Core Labs. LP v. Spectrum Tracer Servs., LLC, No. 2013-1263 (Fed. Cir. Aug. 7, 2013) (non-precedential). On appeal from W.D. Okla. Before Newman, Lourie, and Taranto. Procedural Posture: Plaintiff appealed the denial of a preliminary injunction against the defendants’ use of trade secret and proprietary information and the …

CAFC partially reverses judgment of noninfringement, reverses denial of permanent injunction, and vacates ongoing royalty rate

  Case: Douglas Dynamics, LLC v. Buyers Prods. Co., No. 2011-1291, 2012-1046, -1057, -1087, -1088 (Fed. Cir. May 21, 2013) (precedential). On appeal from W.D. Wis. Before Rader, Newman, and Mayer. Procedural Posture: Plaintiff patentee appealed from summary judgment of noninfringement of one patent and final judgment denying permanent injunction as …

CAFC affirms denial of request for anti-suit injunction

  Case: Sanofi-Aventis Deutschland GmbH v. Genentech, Inc., No. 2012-1454 (Fed Cir. May 8, 2013) (precedential). On appeal from N.D. Cal. Before Rader, Dyk and Reyna. Procedural Posture: Defendant Genentech appealed from the district court’s denial of its request for an anti-suit injunction that would have enjoined Plaintiff Sanofi-Aventis from continuing …